S
Shinae Kizaka-Kondoh
Researcher at Tokyo Institute of Technology
Publications - 110
Citations - 4936
Shinae Kizaka-Kondoh is an academic researcher from Tokyo Institute of Technology. The author has contributed to research in topics: Tumor hypoxia & Gene. The author has an hindex of 36, co-authored 102 publications receiving 4399 citations. Previous affiliations of Shinae Kizaka-Kondoh include Kyoto University.
Papers
More filters
Journal ArticleDOI
Induction of hypoxia-inducible factor 1 activity by muscarinic acetylcholine receptor signaling.
Kiichi Hirota,Ryo Fukuda,Satoshi Takabuchi,Shinae Kizaka-Kondoh,Takehiko Adachi,Kazuhiko Fukuda,Gregg L. Semenza +6 more
TL;DR: It is concluded that muscarinic acetylcholine signals activate HIF-1 by both stabilization and synthesis of Hif-1α and by inducing the transcriptional activity of HIF -1α.
Journal ArticleDOI
The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts.
Hiroshi Harada,Shinae Kizaka-Kondoh,Satoshi Itasaka,Keiko Shibuya,Akiyo Morinibu,Kazumi Shinomiya,Masahiro Hiraoka +6 more
TL;DR: A novel HIF-1-dependent reporter gene is constructed, 5HREp-ODD-luc, in which 5 copies of the hypoxia-response element (5HRE) enhance expression of the oxygen-dependent degradation (ODD) domain and luciferase (luc) fusion under Hypoxia, which will surely accelerate analysis of the intratumoral Hif-1 activity during tumor progression and cancer treatments.
Journal ArticleDOI
Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow.
Youshi Fujita,Masafumi Ihara,Takashi Ushiki,Takashi Ushiki,Hideyo Hirai,Shinae Kizaka-Kondoh,Masahiro Hiraoka,Hidefumi Ito,Ryosuke Takahashi +8 more
TL;DR: BMMNC treatment provides marked protection against ischemic WM damage, enhancing CBF in the early phase and in subsequent angiogenesis, both of which involve nitric oxide synthase activation.
Journal ArticleDOI
Biomedical applications of imidazolium cation-modified iron oxide nanoparticles
Kensuke Naka,Asako Narita,Hirokazu Tanaka,Yoshiki Chujo,Masahito Morita,Toshiro Inubushi,I. Nishimura,J. Hiruta,H. Shibayama,M. Koga,S. Ishibashi,J. Seki,Shinae Kizaka-Kondoh,Masahiro Hiraoka +13 more
TL;DR: In this paper, the synthesis of N-methylimidazolium chloride-modified iron oxide nanoparticles (MImCl-NPs) by condensation of an imidazolate cation-containing silane coupling agent was reported.
Journal ArticleDOI
Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation.
Tetsuya Kadonosono,Akihiro Yamano,Toshiki Goto,Takuya Tsubaki,Mizuho Niibori,Takahiro Kuchimaru,Shinae Kizaka-Kondoh +6 more
TL;DR: It is reported that CPP/PTDs facilitate the extravasation of fused proteins by binding to neuropilin-1 (NRP1), a vascular endothelial growth factor co-receptor expressed on the surface of endothelial and some tumor cells.